Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Izcargo approved in Japan for the treatment of MPS II

March 24, 2021

FDA approves Zegalogue to treat severe hypoglycemia in children and adults with diabetes

March 23, 2021

Tildacerfont: 12-week extension study data presented in patients with CAH

March 23, 2021

SOV-2012-F1, oral testosterone formulation that improves patient satisfaction scores

March 23, 2021

Encouraging preliminary phase I data for RP-L301 in pyruvate kinase deficiency

March 23, 2021

AZP-3601 shows promising preliminary data in healthy male subjects

March 22, 2021

Enrollment opens in first-in-human study of mRNA-3927 for propionic acidemia

March 22, 2021

Dual labeling study finds no evidence of pancreatic beta cell neogenesis

March 19, 2021

High blood fats, sugars alter antigen processing

March 18, 2021

VX-880 enters phase I/II trial for type 1 diabetes

March 12, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 29, 2026.
ENCALS 2026: From genetics to advancing strategies against ALS
BioWorld Science
Amyotrophic lateral sclerosis (ALS)-associated genes provide direct therapeutic targets and reveal pathways that can be used to develop treatments that counteract...
Next wave of BCI firms builds on pioneers to tackle challenges
BioWorld
With the pace of neurotechnology development accelerating, a wave of brain-computer interface (BCI) companies is emerging on the heels of the pioneers. In the...
Boehringer Ingelheim identifies new mGlu3 receptor agonists
BioWorld Science
Boehringer Ingelheim Pharma GmbH & Co. KG and Vanderbilt University have discovered new dihydrobenzoxazine compounds acting as metabotropic glutamate mGlu3...
GT-02897 exerts efficacy in preclinical multiple myeloma
BioWorld Science
Investigators from the Karl Landsteiner University aimed to evaluate the therapeutic potential of a novel CDK9 inhibitor/degrader, GT-02897, for the potential...